Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of $4.41 million. The enterprise value is $4.83 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
XAGE has 1.48 million shares outstanding. The number of shares has increased by 40.07% in one year.
Current Share Class | 1.48M |
Shares Outstanding | 1.48M |
Shares Change (YoY) | +40.07% |
Shares Change (QoQ) | +42.27% |
Owned by Insiders (%) | 7.65% |
Owned by Institutions (%) | 10.86% |
Float | 1.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.46 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 8.61 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42
Current Ratio | 0.42 |
Quick Ratio | 0.18 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -176.88 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -67.31% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 157.12% |
Revenue Per Employee | $37,378 |
Profits Per Employee | -$573,545 |
Employee Count | 15 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | -97,279 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.17% in the last 52 weeks. The beta is 0.56, so XAGE's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | -96.17% |
50-Day Moving Average | 4.05 |
200-Day Moving Average | 9.21 |
Relative Strength Index (RSI) | 42.44 |
Average Volume (20 Days) | 1,332,967 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XAGE had revenue of $560,671 and -$8.60 million in losses. Loss per share was -$11.19.
Revenue | 560,671 |
Gross Profit | 313,784 |
Operating Income | -5.12M |
Pretax Income | n/a |
Net Income | -8.60M |
EBITDA | -5.04M |
EBIT | -5.12M |
Loss Per Share | -$11.19 |
Full Income Statement Balance Sheet
The company has $770,047 in cash and $776,588 in debt, giving a net cash position of -$6,541 or -$0.00 per share.
Cash & Cash Equivalents | 770,047 |
Total Debt | 776,588 |
Net Cash | -6,541 |
Net Cash Per Share | -$0.00 |
Equity (Book Value) | -3.81M |
Book Value Per Share | -3.79 |
Working Capital | -3.81M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -4.07M |
Capital Expenditures | n/a |
Free Cash Flow | -4.07M |
FCF Per Share | -$2.74 |
Full Cash Flow Statement Margins
Gross Margin | 55.97% |
Operating Margin | -914.07% |
Pretax Margin | -1,551.79% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
XAGE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -40.07% |
Shareholder Yield | -40.07% |
Earnings Yield | -178.42% |
FCF Yield | -84.33% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 14, 2025. It was a reverse split with a ratio of 0.0333333:1.
Last Split Date | May 14, 2025 |
Split Type | Reverse |
Split Ratio | 0.0333333:1 |
Scores
XAGE has an Altman Z-Score of -33.98 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -33.98 |
Piotroski F-Score | 1 |